Human albumin administration in critically ill patients. Validity of review methods must be assessed.
作者信息
Soni N
出版信息
BMJ. 1998 Sep 26;317(7162):883-4.
PMID:9786697
Abstract
摘要
相似文献
1
Human albumin administration in critically ill patients. Validity of review methods must be assessed.危重症患者使用人白蛋白。必须评估综述方法的有效性。
BMJ. 1998 Sep 26;317(7162):883-4.
2
3
[Excess mortality in critically ill patients after treatment with human albumin].[人血白蛋白治疗后重症患者的超额死亡率]
Ned Tijdschr Geneeskd. 1998 Aug 15;142(33):1855-8.
4
Human albumin administration in critically ill patients. Paper failed to mention earlier review.危重症患者使用人白蛋白。该论文未提及早期综述。
BMJ. 1998 Sep 26;317(7162):884.
5
Human albumin administration in critically ill patients. I would not want an albumin transfusion.危重症患者输注人白蛋白。我不想输注白蛋白。
BMJ. 1998 Sep 26;317(7162):885.
6
Human albumin administration in critically ill patients. Some patients may benefit.在危重症患者中输注人白蛋白。部分患者可能获益。
BMJ. 1998 Sep 26;317(7162):885-6.
7
8
9
10
Proscribing the use of albumin in the head-injured patient is not warranted.不应当禁止在头部受伤患者中使用白蛋白。
Anesth Analg. 2011 Aug;113(2):426-7; author reply 427-8. doi: 10.1213/ANE.0b013e31821ed699.
引用本文的文献
1
Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis.用于肝硬化和大量腹水且接受腹腔穿刺术治疗患者的血浆扩容剂。
Cochrane Database Syst Rev. 2019 Jun 28;6(6):CD004039. doi: 10.1002/14651858.CD004039.pub2.
2
Prospective meta-analysis using individual patient data in intensive care medicine.前瞻性荟萃分析，使用重症监护医学中的个体患者数据。
Intensive Care Med. 2010 Jan;36(1):11-21. doi: 10.1007/s00134-009-1650-x. Epub 2009 Sep 18.
3
Debate: Albumin administration should not be avoided.辩论：不应避免使用白蛋白。
Crit Care. 2000;4(3):147-50. doi: 10.1186/cc687.
Zotero 插件